Search

Your search keyword '"Janssens, Stefan"' showing total 294 results

Search Constraints

Start Over You searched for: Author "Janssens, Stefan" Remove constraint Author: "Janssens, Stefan" Database Unpaywall Remove constraint Database: Unpaywall
294 results on '"Janssens, Stefan"'

Search Results

1. Characteristics and Management of Patients With Cancer and Atrial Fibrillation

3. Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

5. Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling

6. OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients

9. The effect of higher or lower mean arterial pressure on kidney function after cardiac arrest: a post hoc analysis of the COMACARE and NEUROPROTECT trials

10. Abstract 18324: Artificial Intelligence ECG as a Novel Method to Detect Cardiotoxicity After Anthracyclines

11. Artificial Intelligence ECG as a Novel Screening Tool to Detect a Newly Abnormal Left Ventricular Ejection Fraction After Anthracycline-Based Cancer Therapy

13. Effect of 24-h blood pressure dysregulations and reduced ocular perfusion pressure in open-angle glaucoma progression

15. Abstract P1093: Safety And Feasibility Of Tissue-engineered Biological Ventricular Assist Devices For Ischemic Cardiomyopathy

18. Abstract P1086: Induced Pluripotent Stem Cell-based Cardiac Tissue Modeling Of Mitogenic Cardiomyopathy In Alström Syndrome

19. Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support

20. Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

22. Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade

23. Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study

24. Urinary Proteomic Signature of Mineralocorticoid Receptor Antagonism by Spironolactone: Evidence from the Randomized-Controlled HOMAGE and PRIORITY Trials

25. Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial

27. GEOGRAPHICAL VARIATION IN PATIENT CHARACTERISTICS AND OUTCOMES IN HFPEF

28. Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury

30. PS-BPP03-3: CARDIOVASCULAR RISK AND METABOLIC CHARACTERIZATION OF METABOLICALLY HEALTHY OBESITY CLASSIFIED BY THE NEWLY PROPOSED DEFINITION: A PROSPECTIVE STUDY

31. PS-C12-3: OPEN-ANGLE GLAUCOMATOUS OPTIC DAMAGE IN RELATION TO SYSTEMIC AND OCULAR PERFUSION PRESSURE

32. PS-C12-4: OPEN-ANGLE GLAUCOMATOUS OPTIC DAMAGE ASSOCIATED WITH DAYTIME AND NOCTURNAL DIPS IN BLOOD PRESSURE

34. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

35. Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure

36. Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction

38. Arteriovenous Fistulae in Chronic Kidney Disease and the Heart: Physiological, Histological, and Transcriptomic Characterization of a Novel Rat Model

40. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

43. Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements

44. SUBCLINICAL MAGNETIC RESONANCE IMAGING MARKERS OF CEREBRAL SMALL VESSEL DISEASE IN RELATION TO AMBULATORY BLOOD PRESSURE MEASUREMENTS

46. OPEN-ANGLE GLAUCOMATOUS OPTIC NEUROPATHY IS RELATED TO DIPS RATHER THAN INCREASES IN THE MEAN ARTERIAL PRESSURE OVER 24-H

47. Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock

49. Impaired biventricular contractile reserve in patients with diastolic dysfunction: insights from exercise stress echocardiography

Catalog

Books, media, physical & digital resources